What Is Informed Consent in a Clinical Trial for Myeloma?
Informed consent for clinical trials is the process of agreeing to go through a clinical trial treatment plan after you have received the necessary information about it — the risks, benefits, alternatives, and potential costs — and understand the considerations.
What You'll Learn Before Signing
The research team behind the clinical trial will make sure you know exactly what you're agreeing to before you give consent for a myeloma clinical trial. You'll learn:
- The purpose of the study.
- Which treatment is being tested.
- How the trial works.
- The potential treatment risks.
- Your rights as a participant.
You can also ask questions and discuss the clinical trial with your medical team to feel fully informed and confident if you decide to participate. If you agree to move forward, you'll sign a consent form.
Benefits of a Myeloma Clinical Trial
When you participate in a clinical trial, you can help medical researchers and the myeloma community in their search for a cure for this disease. Some possible benefits of participating include:
- Access to innovative therapies: Clinical trials test new treatments in development or new uses for existing treatments. Participants often get early access to these therapies, which may be better than treatment options currently on the market. Depending on the trial design, you may continue to receive your standard myeloma treatment during the clinical trial.
- High-quality care: During the clinical trial, you'll work with researchers who have expertise in multiple myeloma treatments. You can learn critical information about myeloma and care standards to help you understand your needs and improve your care plan with your medical team.
- Advancement of myeloma research: Your participation can help researchers find new treatments and develop new multiple myeloma drugs. Even if the therapy tested in the clinical trial is not developed, the process still provides researchers with valuable data to make advancements.
Known and Potential Risks of Participating in Multiple Myeloma Clinical Trials
Any clinical trial can come with a degree of risk. Here are some of the risks or potential downsides of participating in a myeloma clinical trial:
- Ineffective treatment: The tested therapy may not be effective or beneficial for your current myeloma treatment. Overall, only about 10-20% of drug candidates that go through clinical trials in the U.S., the European Union, and Japan receive marketing approval.
- Side effects: New medications often come with side effects. Understanding the risk of adverse reactions before consenting to the myeloma clinical trial is important.
- Travel requirements: The location of the trial, as well as the medical appointments, procedures, and medication regimens, may require you to travel, live away from home for a short period, and invest significant time in your participation.
Costs of Participating in a Myeloma Clinical Trial
Clinical trials involve two main costs:
- Research costs: The research costs are the expenses involved in participating in the trial. Drug companies, research foundations, and government grants sponsor many clinical trials, often covering these costs and providing participants with access to the drug. As a result, you may be able to access treatments that could otherwise be financially inaccessible to you.
- Patient care costs: These include expenses for care received during the trial, such as doctor's appointments, hospital stays, testing, travel, food, and housing. Your health insurance may cover these costs.
Questions to Ask Before Joining a Clinical Trial
Before giving your consent, ask the clinical trial team questions about the trial, such as:
- What is expected of me as a participant?
- Who is funding this study?
- Will this trial give placebo treatments to participants?
- Can I continue my standard myeloma treatment during the trial?
- What are the risks and benefits?
- How long will the clinical trial last?
- Which tests, procedures, and treatments will I undergo during the clinical trial?
Can You Withdraw Consent From a Clinical Trial?
After you are enrolled in the trial, you are allowed to change your mind and exit the trial whenever you want to, regardless of the reason. If you withdraw consent, the clinical trial team will provide guidance, such as whether you'll still need to have checkups.
Where to Find Myeloma Clinical Trials
Individuals living with myeloma can use the Clinical Trials Matching Engine from the International Myeloma Foundation (IMF). This tool helps you find clinical trials, so you can explore and learn more about treatment options. The engine has filters to search for clinical trials by distance, diagnosis, and treatment history. The National Cancer Institute has many myeloma clinical trials listed on its website.
Get More Information About Multiple Myeloma Clinical Trials
Explore additional care options for myeloma and advance research on prevention and cure by joining a clinical trial. Use the Clinical Trials Matching Engine to find a study in your area, or call the IMF InfoLine Coordinator at 1-800-452-CURE (2873) or more information, resources, and support.




